Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
出版年份 2020 全文链接
标题
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
作者
关键词
-
出版物
Nature Communications
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-10
DOI
10.1038/s41467-020-18387-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Identification of a novel coronavirus causing severe pneumonia in human
- (2020) Li-Li Ren et al. CHINESE MEDICAL JOURNAL
- COVID-19: towards controlling of a pandemic
- (2020) Juliet Bedford et al. LANCET
- Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
- (2019) Marie Scully et al. NEW ENGLAND JOURNAL OF MEDICINE
- Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
- (2019) Jean K. Millet et al. Jove-Journal of Visualized Experiments
- Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
- (2019) Tugrul Elverdi et al. Drug Design Development and Therapy
- Clinical pharmacology of caplacizumab for the treatment of patients with acquired thrombotic thrombocytopenic purpura
- (2019) Maria Laura Sargentini-Maier et al. Expert Review of Clinical Pharmacology
- Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial)
- (2019) L. J. Estcourt TRANSFUSION MEDICINE
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
- (2018) Guangyu Zhao et al. JOURNAL OF VIROLOGY
- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection
- (2018) V. Stalin Raj et al. Science Advances
- Nanobodies as therapeutics: big opportunities for small antibodies
- (2016) Sophie Steeland et al. DRUG DISCOVERY TODAY
- Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus
- (2016) Gökçe Günaydın et al. Scientific Reports
- NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies
- (2016) Sandrine Moutel et al. eLife
- Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake
- (2015) Maarten Rotman et al. NUCLEAR MEDICINE AND BIOLOGY
- Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
- (2015) Davide Corti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
- (2014) Tianlei Ying et al. JOURNAL OF VIROLOGY
- General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
- (2008) Cécile Vincke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started